About the Company : Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20...
Guizhou Utide Biotechnology Co., Ltd, founded in 2016 and headquartered in Zunyi, Guizhou, specializes in GLP-1 peptide APIs. With 20,000 sqm facilities and a core team boasting 20+ years in peptide R&D, manufacturing, route development, and scale-up, we operate Phase I/II sites (1,500–1,800 kg annual capacity) with Phase III expansion underway. US DMFs filed for retatrutide and tirzepatide; global filings in progress. Supported by teams in Guizhou, Shenzhen, and Hong Kong, we deliver high-purity APIs and custom solutions to pharma partners worldwide.